Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0999
0.00 (0.00%)
Apr 29, 2024, 9:30 AM EDT - Market closed
Nascent Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Year | Current | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 16 | 7 | 6 | 4 | 9 | 5 | 6 | 7 | 8 | 15 | 1 | Upgrade
|
| Market Cap Growth | - | 8.60% | 36.92% | -51.34% | 71.13% | -16.76% | -12.69% | -6.21% | -48.64% | 1381.39% | 0% | Upgrade
|
| Enterprise Value | 16 | 7 | 6 | 5 | 9 | 5 | 6 | 7 | 7 | 15 | 1 | Upgrade
|
| PE Ratio | -35.19 | -2.38 | -41.58 | -3.41 | -2.25 | -3.93 | -2.91 | 6.52 | -1.90 | -7.14 | -0.54 | Upgrade
|
| PS Ratio | - | - | 6.14 | 5.98 | - | - | - | 2.47 | - | - | - | Upgrade
|
| PB Ratio | 542.16 | -5.15 | -9.15 | -9.49 | -3.21 | -11.17 | -74.91 | 10.10 | -5.04 | -6.97 | -0.72 | Upgrade
|
| P/FCF Ratio | -23.68 | -3.73 | 14.85 | -4.55 | -16.63 | -7.57 | -5.29 | -9.64 | -46.37 | -11.82 | -7.99 | Upgrade
|
| P/OCF Ratio | -23.68 | -3.73 | 14.85 | -4.55 | -16.63 | -7.57 | -5.29 | -9.64 | -46.37 | -32.51 | -7.99 | Upgrade
|
| EV/Sales Ratio | - | - | 6.05 | 6.19 | - | - | - | 2.43 | - | - | - | Upgrade
|
| EV/EBITDA Ratio | -12.61 | -3.19 | -9.94 | -3.27 | -2.71 | -3.84 | -2.86 | 5.10 | -1.89 | -7.21 | -0.48 | Upgrade
|
| EV/EBIT Ratio | -9.91 | -1.97 | - | - | - | - | - | - | - | - | - | Upgrade
|
| EV/FCF Ratio | -23.28 | -3.85 | 14.62 | -4.71 | -16.87 | -7.38 | -5.19 | -9.47 | -43.01 | -11.79 | -7.14 | Upgrade
|
| Debt / Equity Ratio | 4.12 | -0.30 | 0 | -0.34 | -0.05 | 0 | 0 | 0 | 1.49 | -0.03 | 0 | Upgrade
|
| Debt / EBITDA Ratio | -0.06 | -0.18 | - | -0.11 | -0.04 | - | - | - | - | -0.03 | - | Upgrade
|
| Debt / FCF Ratio | -0.10 | -0.22 | - | -0.16 | -0.25 | - | - | - | - | -0.05 | - | Upgrade
|
| Quick Ratio | 1.02 | 0.11 | 0.12 | 0.61 | 0.00 | 0.21 | 0.58 | 0.78 | 0.19 | 0.03 | 0.07 | Upgrade
|
| Current Ratio | 1.05 | 0.16 | 0.14 | 0.61 | 0.00 | 0.21 | 0.58 | 0.78 | 0.19 | 0.04 | 0.08 | Upgrade
|
| Asset Turnover | 0 | 0 | 9.49 | 1.00 | 0 | 0 | 0 | 3.33 | 0 | 0 | 0 | Upgrade
|
| Interest Coverage | -14.64 | -1.25 | -1.36 | -4.16 | -39.79 | 0 | 0 | 26.37 | -13.80 | -88.33 | 191.00 | Upgrade
|
| Return on Equity (ROE) | -6892.89% | 216.10% | 22.00% | 278.26% | 142.25% | 283.91% | 2571.57% | 154.95% | 264.50% | 97.69% | 133.79% | Upgrade
|
| Return on Assets (ROA) | -326.40% | -1098.41% | -140.12% | -174.97% | -127121.78% | -1041.22% | -1898.64% | 126.36% | -296.12% | -229.95% | -1616.67% | Upgrade
|
| Return on Capital (ROIC) | -1450.55% | 237.80% | 68.07% | 450.61% | 125.96% | 283.92% | 2572.12% | 160.63% | 246.69% | 98.74% | 131.72% | Upgrade
|
| Earnings Yield | -12.71% | -42.00% | -2.41% | -29.31% | -44.38% | -25.42% | -34.33% | 15.34% | -52.51% | -14.01% | -186.79% | Upgrade
|
| FCF Yield | -7.42% | -26.80% | 6.73% | -22.00% | -6.01% | -13.22% | -18.92% | -10.37% | -2.16% | -8.46% | -12.52% | Upgrade
|
| Buyback Yield / Dilution | -39.95% | -10.05% | -48.93% | -110.34% | -14.30% | -16.25% | -18.74% | -10.26% | -41.32% | 19.18% | - | Upgrade
|
| Total Shareholder Return | -39.95% | -10.05% | -48.93% | -110.34% | -14.30% | -16.25% | -18.74% | -10.26% | -41.32% | 19.18% | - | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.